Silo Pharma
SILO
13 hedge funds and large institutions have $256K invested in Silo Pharma in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
0.24% more ownership
Funds ownership: 0.37% → 0.6% (+0.24%)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
10% less capital invested
Capital invested by funds: $285K → $256K (-$28.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$45.8K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$33K |
| 3 |
UFM
Ursa Fund Management
Danville,
California
|
+$28.6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$20.5K |
| 5 |
Citigroup
New York
|
+$7.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Conning Inc
Hartford,
Connecticut
|
-$23.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$3.96K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$585 |
SILO Hedge Fund Activity: Q2 2025 in Review
13 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q2 2025, worth a combined $256K — down 10% from $285K a quarter earlier.
Fund positioning in SILO was balanced in Q2 2025: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 1 trimmed.
The largest buyer was AdvisorShares Investments, adding an estimated $45.8K. The largest seller was Conning Inc, exiting entirely with an estimated $23.4K sold.
- 13 institutional investors held Silo Pharma (SILO) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $256K of Silo Pharma stock for Q2 2025, down 10% quarter-over-quarter.
- 3 funds opened new Silo Pharma positions in Q2 2025 and 3 closed out, a net change of 0 holders.
- The largest Silo Pharma buyer in Q2 2025 was AdvisorShares Investments, an estimated $45.8K added.
- The largest Silo Pharma seller in Q2 2025 was Conning Inc, an estimated $23.4K sold.
Based on aggregated 13F filings for Q2 2025.